Israel Englander Acurx Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.47 - $3.53 $11,715 - $16,742	-4,743 Reduced 21.51%	17,308 $45,000
Q1 2023 May 15, 2023	SELL	$3.06 - $4.5 $21,557 - $31,702	-7,045 Reduced 24.21%	22,051 $76,000
Q4 2022 Feb 14, 2023	SELL	$2.75 - $4.1 $50,297 - $74,989	-18,290 Reduced 38.6%	29,096 $116,000
Q3 2022 Nov 14, 2022	BUY	$3.0 - $4.78 $142,158 - $226,505	47,386 New	47,386 $142,000

1.29M

9.3K

9.7K

Ticker ACXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,556,600
Market Cap $8.9M
Description
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.